It was pointed out to me that I missed a very impo
Post# of 148279
> the Cost to run a new trial in HIV combo. Let's put that at $125 million.
> So we had $375 million + $125 million or $500 million
> Plus the loss in market capitalization from a high of $1 billion to $250 million or a loss of $750 million market cap
> Just CytoDyn's costs $1,250,000,000 without adding in what Sidley Austins Economic Accountants shall quantify as additional losses, punitive and compensatory. They will Prove such quantities.